Scribd
Upload
15 views

psm tb @Dr_cjs

psm tb @Dr_cjs

Uploaded by

tariqkhanmahsud20
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
15 views

psm tb @Dr_cjs

psm tb @Dr_cjs

Uploaded by

tariqkhanmahsud20
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 20

Kashish Grover, PSM Faculty

HIV TB Course
TB and NTEP

1
SDGs and TB
The United Nations Sustainable Development Goals (SDGs) include ending the TB
epidemic by 2030 under Goal 3.
Goal 3.3: By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected
tropical diseases and combat hepatitis, water-borne diseases and other communicable
diseases.

Dr. Kashish Grover, PSM faculty DAMS 2


END TB Strategy

Dr. Kashish Grover, PSM faculty DAMS 3


National Strategic Plan (2020-2025)

Dr. Kashish Grover, PSM faculty DAMS 4


Dr. Kashish Grover, PSM faculty DAMS 5
Tuberculosis Unit

6
Dr. Kashish Grover, PSM faculty DAMS
Dr. Kashish Grover, PSM faculty DAMS 7
TB Case finding

Passive Case finding Active Case finding


It refers to a person-initiated It refers to the systematic
pathway to TB diagnosis. screening for active TB in at-risk
Intensified case finding is a populations, typically
component of passive case implemented outside the health
finding which involves facilities (community or
systematic screening of all congregate settings).
people seeking care in a
health facility or a clinic for Contact tracing is a component of
identification of people at active case finding.
risk for TB.
Dr. Kashish Grover, PSM faculty DAMS 8
Dr. Kashish Grover, PSM faculty DAMS 9
TB Prevention
• TB preventive treatment (TPT) for high-risk populations and
• Airborne infection control (AIC) in health care and other settings.

Dr. Kashish Grover, PSM faculty DAMS 10


TB Preventive Therapy
Whom to start
People living with HIV (+ ART) TPT to all after ruling out active TB disease
• Adults and children >12 months
• Infants < 12 months with HIV in
contact with active TB patient
• HHC below 5 years of pulmonary TB
patients
• HHC 5 years and above of TPT after ruling out TB disease among TBI positive*
pulmonary TB patients
*Tuberculin Skin Test (TST) and Interferon-Gamma Release Assay (IGRA)
• Individuals who are:
• on immunosuppressive therapy
• having silicosis
• on anti-TNF treatment
• on dialysis
• preparing for organ or
hematologic transplantation

Dr. Kashish Grover, PSM faculty DAMS 11


TB Preventive Therapy
Contraindications Regimens
1. Active TB disease 6H 3HP
2. Acute or chronic hepatitis
3. Concurrent use of other Drugs Isoniazid Isoniazid +
hepatotoxic medications rifapentine
4. Regular and heavy alcohol Duration 6 months 3 months
consumption
5. Signs and symptoms of peripheral Interval Daily weekly
neuropathy like persistent tingling,
numbness and burning sensation Doses 182 12
in the limbs
6. Allergy or known hypersensitivity Pregnant Safe Not known
to any drugs being considered for
With ART No restriction Restrictions
TPT
Dr. Kashish Grover, PSM faculty DAMS 12
TB Preventive Therapy
DRTB contact
6lfx 4R

Drugs Levofloxacin Rifampicin

Duration 6 months 4 months

Interval Daily Daily

Doses for contacts of R for contacts of H


resistant FQ resistant R
sensitive patients sensitive
patients

Dr. Kashish Grover, PSM faculty DAMS 13


Dr. Kashish Grover, PSM faculty DAMS 14
Call Centre Support Ni-kshay SAMPARK (1800-11-6666)
Patient support system
Direct Benefit Transfer (DBT): Amount
Ni-kshay Poshan Yojana (NPY) Confirmed TB Patients (DSTB &
DRTB)
Public + Private Sector Patients

Honorarium for Treatment Supporters Confirmed TB Patients residing in


Tribal/Hilly/Difficult blocks

Transport support for TB patients in Treatment Supporter


notified tribal/hilly/difficult areas

Notification & Treatment Outcome Private Health Facilities:


Incentive for Private Sector Providers Practitioner / Clinic etc. (Single)
including informants incentive: Hospital/ Clinic/ Nursing Home
Laboratories, Chemists
Any person as informants
TPT supporter ASHAs or Community Health
Volunteers
15
Dr. Kashish Grover, PSM faculty DAMS 16
Partnership under NTEP
• Provision of free diagnostics under NTEP
• Provision of government FDCs to the patients seeking care from private sector.
• Incentives for private providers for notification, treatment outcomes or referral (wherever
applicable).
• Incentives to patients seeking care from private sector in the form of Nikshay Poshan Yojana.
System for TB Elimination in Private Sector (STEPS) approach:
A single window solution is provided for notification, linkage for public health actions, and treatment
adherence support in private hospitals by identifying nodal persons from the health facility itself. This is
being practiced in Kerala and Karnataka

Dr. Kashish Grover, PSM faculty DAMS 17


Dr. Kashish Grover, PSM faculty DAMS 18
Community Engagement
Ni-kshay Mitra
• The Ni-Kshay Mitra shall provide additional
support to all the on-treatment TB patients
who have given consent for support.
• The support shall include the following:
a. Nutritional support
b. Additional investigations for the
diagnosed TB patients
c. Vocational support
d. Additional nutritional supplements
• The minimum period shall be six months.

Dr. Kashish Grover, PSM faculty DAMS 19


Thank You..!!
In case any doubt, feel free to connect

Dr. Kashish Grover


MBBS, MD (PSM)
Faculty DAMS
Instagram: @kays_psm
Telegram: @kays_psm

20

You might also like